What we know so far
|Expected raise:||$17 million|
We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Clinical diagnostics company Haemokinesis is set to list soon on the Australian Securities Exchange (ASX), which means that you'll be able to buy company shares. Here's what we know about the initial public offering (IPO), including how to invest before it lists and how to buy in when it lists.
To invest in an IPO, you'll typically need to be registered with a participating broker or lead manager. This can be tricky for regular investors because only a few firms are allocated IPO stock and they're most often full-service brokers. In this case, the IPO is being lead managed by PAC Partners Securities Pty Ltd.
If you're already registered with a broker, it always pays to check if they're offering pre-listed IPO stock, as lead managers sometimes allocate a portion of shares on to other firms. Your other option is to buy shares in Haemokinesis once it goes public. To do that, you'll need to be signed up to a share trading platform:
Haemokinesis lodged its prospectus with the Australian Securities and Investments Commission (ASIC) to list on the ASX under the ticker symbol HKX.
PAC Partners Securities Pty Ltd were appointed as lead managers with an expected raise of $17 million at $0.20 per share. You can check out some of the key dates and figures in the table below:
|Haemokinesis IPO key numbers|
|Total number of shares available under the offer||85,000,000|
|Proposed ASX code||ASX: HKX|
|Target market cap||$77,399,064|
|Retail offer opens||2 March 2022|
|Retail offer closes||23 March 2022|
|Expected listing on ASX||TBA|
|Expected dispatch of holding statements||29 March 2022|
According to latest information available, retail investors (regular investors) have between 2 March 2022 and 23 March 2022 to participate in the Haemokinesis IPO. After the retail offer close date, you'll need to wait until the stock is publicly available on the ASX to buy shares.
We update our data regularly, but information can change between updates. Confirm details with the provider you're interested in before making a decision.
Haemokinesis launched in 2011 by Mr. Jim Manolios and is headquartered in Melbourne, Australia.
Steps to owning and managing Pacific Edge shares.
Everything we know about the Aeramentum Resources IPO, plus information on how to buy in.
Everything we know about the OD6 Metals IPO, plus information on how to buy in.
Steps to owning and managing Winton Land shares.
Everything we know about the Summit Minerals IPO, plus information on how to buy in.
The picks and shovels approach is one way to gain exposure to the crypto market. Here is an ETF you could consider.
Everything we know about the Regener8 Resources IPO, plus information on how to buy in.
While crypto ETFs remain a relatively new concept, here is how you can invest in one of the first physically back Bitcoin ETFs.
Here is your how to guide on buying the first Ethereum backed ETF in Australia.
finder.com.au is one of Australia's leading comparison websites. We compare from a wide set of banks, insurers and product issuers. We value our editorial independence and follow editorial guidelines.
finder.com.au has access to track details from the product issuers listed on our sites. Although we provide information on the products offered by a wide range of issuers, we don't cover every available product or service.
Please note that the information published on our site should not be construed as personal advice and does not consider your personal needs and circumstances. While our site will provide you with factual information and general advice to help you make better decisions, it isn't a substitute for professional advice. You should consider whether the products or services featured on our site are appropriate for your needs. If you're unsure about anything, seek professional advice before you apply for any product or commit to any plan.
Products marked as 'Promoted' or 'Advertisement' are prominently displayed either as a result of a commercial advertising arrangement or to highlight a particular product, provider or feature. Finder may receive remuneration from the Provider if you click on the related link, purchase or enquire about the product. Finder's decision to show a 'promoted' product is neither a recommendation that the product is appropriate for you nor an indication that the product is the best in its category. We encourage you to use the tools and information we provide to compare your options.
Where our site links to particular products or displays 'Go to site' buttons, we may receive a commission, referral fee or payment when you click on those buttons or apply for a product. You can learn more about how we make money here.
When products are grouped in a table or list, the order in which they are initially sorted may be influenced by a range of factors including price, fees and discounts; commercial partnerships; product features; and brand popularity. We provide tools so you can sort and filter these lists to highlight features that matter to you.
We try to take an open and transparent approach and provide a broad-based comparison service. However, you should be aware that while we are an independently owned service, our comparison service does not include all providers or all products available in the market.
Some product issuers may provide products or offer services through multiple brands, associated companies or different labelling arrangements. This can make it difficult for consumers to compare alternatives or identify the companies behind the products. However, we aim to provide information to enable consumers to understand these issues.
Providing or obtaining an estimated insurance quote through us does not guarantee you can get the insurance. Acceptance by insurance companies is based on things like occupation, health and lifestyle. By providing you with the ability to apply for a credit card or loan, we are not guaranteeing that your application will be approved. Your application for credit products is subject to the Provider's terms and conditions as well as their application and lending criteria.